Related Experiment Video
Updated: Mar 22, 2026

09:52
An Implantable System For Chronic In Vivo Electromyography
Published on: April 21, 2020
11.4K
GNAL mutation in isolated laryngeal dystonia
Gregory G Putzel1, Tania Fuchs1, Giovanni Battistella1
1Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Summary
Genetic factors in laryngeal dystonia are suspected, but causes are unknown. A GNAL gene mutation was identified in one patient, suggesting it as a rare genetic cause with distinct brain activity patterns.
Area of Science:
- Genetics
- Neurology
- Movement Disorders
Background:
- Familial history in 12% of laryngeal dystonia patients suggests genetic involvement.
- The specific genetic causes of laryngeal dystonia remain largely unknown.
- Laryngeal dystonia is a complex neurological movement disorder affecting voice production.
Purpose of the Study:
- To investigate known dystonia genes for mutations in patients with isolated laryngeal dystonia.
- To explore the impact of identified mutations on brain activation patterns using functional MRI.
Main Methods:
- Sanger sequencing was used to screen 57 patients for mutations in TOR1A, THAP1, TUBB4A, and GNAL genes.
- Functional MRI (fMRI) was employed to assess brain activity during symptomatic tasks in a mutation carrier.
- Comparison of brain activation between a GNAL mutation carrier and patients without known mutations.
Main Results:
- One patient with isolated laryngeal dystonia was identified as a GNAL mutation carrier.
- The GNAL carrier exhibited increased fronto-parietal cortex activity compared to controls.
- Reduced cerebellar activity was observed in the GNAL mutation carrier.
Conclusions:
- GNAL mutations represent a rare genetic cause of isolated laryngeal dystonia.
- Distinct neural abnormalities in GNAL carriers may indicate divergent pathophysiological mechanisms.
- Further research is needed to elucidate the role of GNAL in laryngeal dystonia.
More Related Videos
Related Concept Videos
Mutations
96.0K
Overview
96.0K
Mutations
45.4K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.4K
Myasthenia Gravis: Diagnostic Tests
3.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.0K
Larynx
6.0K
The human larynx, often referred to as the voice box, is an intricate organ located in the neck. It serves as a pathway for air to enter the lungs during respiration and is an essential component of voice production.
Anatomy of the Larynx
The larynx consists of various components, including cartilage, muscles, and vocal cords. Its structure includes three large unpaired cartilages—the thyroid, cricoid, and epiglottis—and three smaller paired cartilages—the arytenoids,...
Anatomy of the Larynx
The larynx consists of various components, including cartilage, muscles, and vocal cords. Its structure includes three large unpaired cartilages—the thyroid, cricoid, and epiglottis—and three smaller paired cartilages—the arytenoids,...
6.0K
Myasthenia Gravis: Overview and Treatment
3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
Skeletal Muscle Relaxants: Therapeutic Uses
1.1K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K

